Recent clinical trials (e.g., CAST and CAST-II) established a cardiotoxic effect of treatment of ventricular arrhythmias with Class I antiarrhythmic agents (Na+ channel blockers). This failure has shifted clinical interest to Class III antiarrhythmic agents (K+ channel blockers). However, antiarrhythmic drugs that block K+ channels vary in selectivity and display conformation specific interactions. Such conformation specific interactions can cause the degree of block of a channel to vary by orders of magnitude depending on the rate, duration and potentials to which the channel is subject. Such conformation dependent binding can be either detrimental or beneficial. This proposal focuses on the relationship between antiarrhythmic drug binding and a particular class of conformational changes, namely C-type inactivation in cardiac K+ channels. C-type inactivation is more widely distributed among cardiac K+ channels than N-type and may be the dominant determinant of such important properties as recovery, K+ sensitivity and drug use-dependent. The goal of this proposal is to elucidate how C-type inactivation can influence the complex patterns of block and use-dependence seen with Class III agents. The central hypothesis is that C-type inactivation involves two conformational changes, closure of the external pore mouth, and closure of the internal pore mouth. Closure of the internal mouth of the channel is proposed to occur through a lipophilic collapse involving the S6 domain. Intracellular lipophilic drug binding promotes this collapse by excluding K+ and increasing the net lipophilic environment. The PI further hypothesizes that the conformational changes in the two regions are not independent but are coupled. The proposed physical and energetic mechanisms will be simulated and tested experimentally to provide a quantitative model of C-type inactivation and antiarrhythmic drug binding. This study will provide a molecular basis for the use dependent properties of a broad class

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL062465-07
Application #
6537568
Study Section
Pharmacology A Study Section (PHRA)
Program Officer
Lathrop, David A
Project Start
2000-07-01
Project End
2003-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
7
Fiscal Year
2002
Total Cost
$247,301
Indirect Cost
Name
State University of New York at Buffalo
Department
Physiology
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Bett, Glenna C L; Kaplan, Aaron D; Rasmusson, Randall L (2016) Action Potential Shape Is a Crucial Measure of Cell Type of Stem Cell-Derived Cardiocytes. Biophys J 110:284-6
Lin, Bo; Li, Yang; Han, Lu et al. (2015) Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy. Dis Model Mech 8:457-66
Rasmusson, Randall L; Anumonwo, Justus M (2015) Activation of HERG channels: opening new applications for the biophysics of antiarrhythmic therapy. Biophys J 108:1309-1311
Kim, Jong J; Yang, Lei; Lin, Bo et al. (2015) Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells. J Mol Cell Cardiol 81:81-93
Gold, Daniel A; Kaplan, Aaron D; Lis, Agnieszka et al. (2015) The Toxoplasma Dense Granule Proteins GRA17 and GRA23 Mediate the Movement of Small Molecules between the Host and the Parasitophorous Vacuole. Cell Host Microbe 17:642-52
Han, Lu; Li, Yang; Tchao, Jason et al. (2014) Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc Res 104:258-69
Parikh, Ashish; Patel, Divyang; McTiernan, Charles F et al. (2013) Relaxin suppresses atrial fibrillation by reversing fibrosis and myocyte hypertrophy and increasing conduction velocity and sodium current in spontaneously hypertensive rat hearts. Circ Res 113:313-21
Bett, Glenna C L; Kaplan, Aaron D; Lis, Agnieszka et al. (2013) Electronic ""expression"" of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells. Heart Rhythm 10:1903-10
Zhou, Qinlian; Bett, Glenna C L; Rasmusson, Randall L (2012) Markov models of use-dependence and reverse use-dependence during the mouse cardiac action potential. PLoS One 7:e42295
Bett, Glenna Cl; Lis, Agnieszka; Wersinger, Scott R et al. (2012) A Mouse Model of Timothy Syndrome: a Complex Autistic Disorder Resulting from a Point Mutation in Cav1.2. N Am J Med Sci (Boston) 5:135-140

Showing the most recent 10 out of 21 publications